EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Claudin‐18 expression in gastric type adenocarcinoma and HPV ‐associated adenocarcinoma of the uterine cervix

Nobuko Yasutake iD, Yuki Yokawa iD, Takehiro Tanaka iD, Riri Mishima iD, Misato Komamizu iD, Ryosuke Kuga iD, Rina Jiromaru iD, Shinichiro Kawatoko iD, Kenzo Sonoda iD, Hideaki Yahata iD, Kiyoko Kato iD, Yoshinao Oda iD und 1 weitere

Histopathology · 2026-04 · 88 (5) · 1003-1015

DOI: 10.1111/his.70066 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Histopathology, online erschienen am 22.12.2025. Verfasst von Nobuko Yasutake und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Claudins, Adenocarcinoma, Papillomavirus Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Claudin‐18 (CLDN18) is both a marker for the gastric phenotype and a therapeutic target. However, little is known about its immunoexpression in endocervical adenocarcinomas (ECAs), particularly as detected using the clone 43‐14A antibody, or about the gene expression of its isoforms in ECAs. Methods and results We examined CLDN18, HIK1083, p16 and Rb expression by immunohistochemistry and high‐risk human papillomavirus (HR‐HPV) mRNA by in situ hybridization (ISH) in 121 ECAs, including 35 HPV‐independent adenocarcinomas (gastric type [GAS], n = 24; non‐GAS, n = 11) and 86 HPV‐associated ECAs. We also analysed mRNA expression of the CLDN18.1 (lung type) and CLDN18.2 (gastric type) isoforms by quantitative polymerase chain reaction (qPCR) in selected cases. CLDN18 positivity was detected in 8/24 (33%) GASs, 0/11 (0%) non‐GASs and 2/86 (2%) HPV‐associated ECAs, with positivity defined as staining in ≥75% of tumour cells, as in gastric cancer. When a 5% cut‐off was used, CLDN18 positivity was detected in 22/24 (92%) GASs, 0/11 (0%) non‐GASs and 6/86 (7%) HPV‐associated ECAs; CLDN18 expression was thus significantly associated with GAS histology ( P < 0.0001). Among the 6 cases of HPV‐associated ECAs with CLDN18 expression (ranging from 5% to 80%), the histological patterns included a mix of usual and mucinous features in 4 cases, pure usual type in 1 and villoglandular variant in 1. Otherwise features such as p16 overexpression and the Rb partial loss pattern were consistent with those of HPV‐associated ECAs. Six of 22 (27%) CLDN18‐positive GASs were also positive for p16, but their other features—such as CLDN18 expression and the Rb preserved pattern—were the same as in p16 negative GASs. Expression of CLDN18.2 mRNA but not CLDN18.1 mRNA was confirmed in both GASs and HPV‐associated ECAs.

Conclusions

CLDN18 (43‐14A) emerged as a potential diagnostic and therapeutic marker for GAS. A minor subset of HPV‐associated ECAs also can be immunoreactive for CLDN18 and express CLDN18.2 mRNA, suggesting divergent gastric phenotypic differentiation. The caution is that GAS and HPV‐associated ECAs can share overlapping histological features and similar expression of CLDN18 and p16.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsClaudinsAdenocarcinomaPapillomavirus InfectionsStomach NeoplasmsHumansFemaleBiomarkers, TumorMiddle AgedImmunohistochemistryAgedAdultIn Situ HybridizationAged, 80 and over

Stichwörter der Autor:innen

claudin‐18endocervical adenocarcinomagastric typehuman papillomavirusp16

Substanzen

ClaudinsCLDN18 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Gynecology and Obstetrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Pathology and Oncology, Graduate School of Medicine, Dentistry & Pharmaceutical Science, Okayama University, Okayama, Japan.
  • Department of Anatomic Pathology, Pathological Sciences, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Medicine and Clinical Science, Kyushu University Beppu Hospital, Beppu, Japan.
  • Department of Gynecology, Kyushu University Beppu Hospital, Beppu, Japan.

ORCID-Profile: Nobuko Yasutake, Yuki Yokawa, Takehiro Tanaka, Riri Mishima, Misato Komamizu, Ryosuke Kuga, Rina Jiromaru, Shinichiro Kawatoko, Kenzo Sonoda, Hideaki Yahata, Kiyoko Kato, Yoshinao Oda, Hidetaka Yamamoto

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Yasutake, N., Yokawa, Y., Tanaka, T., Mishima, R., Komamizu, M., Kuga, R., Jiromaru, R., Kawatoko, S., Sonoda, K., Yahata, H., Kato, K., Oda, Y., & Yamamoto, H. (2026). Claudin‐18 expression in gastric type adenocarcinoma and HPV ‐associated adenocarcinoma of the uterine cervix. Histopathology, 88(5), 1003-1015. https://doi.org/10.1111/his.70066

Vancouver

Yasutake N, Yokawa Y, Tanaka T, Mishima R, Komamizu M, Kuga R, et al. Claudin‐18 expression in gastric type adenocarcinoma and HPV ‐associated adenocarcinoma of the uterine cervix. Histopathology. 2026;88(5):1003-1015. doi:10.1111/his.70066

BibTeX
@article{Yasutake2026,
  author = {Yasutake, Nobuko and Yokawa, Yuki and Tanaka, Takehiro and Mishima, Riri and Komamizu, Misato and Kuga, Ryosuke and Jiromaru, Rina and Kawatoko, Shinichiro and Sonoda, Kenzo and Yahata, Hideaki and Kato, Kiyoko and Oda, Yoshinao and Yamamoto, Hidetaka},
  title = {Claudin‐18 expression in gastric type adenocarcinoma and HPV ‐associated adenocarcinoma of the uterine cervix},
  journal = {Histopathology},
  year = {2026},
  volume = {88},
  number = {5},
  pages = {1003--1015},
  doi = {10.1111/his.70066}
}
Kostenlos starten →